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Objective:Nonlaminar shear stress stimulates smoothmuscle cell (SMC) proliferation andmigration in vivo, especially after an
endothelial-denuding injury. To determine whether sustained shear stress directly stimulates SMC proliferation in vitro, the
effect of orbital shear stress on SMCproliferation, phenotype, and extracellular signal-regulated protein kinase 1/2 (ERK1/2)
phosphorylation was examined.
Methods: Bovine SMCs were exposed to orbital shear stress (210 rpm) for up to 10 days, with and without the ERK1/2
upstream pathway inhibitor PD98059 (10M) or the p38 pathway inhibitor SB203580 (10M). Proliferation was directly
counted and assessed with proliferation cell nuclear antigen. Western blotting was used to assess activation of SMC ERK1/2
and SMC phenotype markers.
Results: SMCs exposed to sustained orbital shear stress (10 days) had 75% increased proliferation after 10 days compared with
static conditions. Expression of markers of the contractile phenotype (-actin, calponin) was decreased, and markers of the
synthetic phenotype (vimentin, -actin) were increased. ERK1/2 was phosphorylated in the presence of orbital shear stress,
and orbital shear-stress-stimulated SMC proliferation was inhibited in the presence of PD98059 but sustained in the presence
of SB203580. Orbital shear-stress-induced changes in SMC phenotype were also inhibited in the presence of PD98059.
Conclusion: Orbital shear stress directly stimulates SMC proliferation in long-term culture in vitro and is mediated, at least
partially, by the ERK1/2 pathway. The ERK1/2 pathway may also mediate the orbital shear-stress-stimulated switch from
SMC contractile to synthetic phenotype. These results suggest that shear-stress-stimulated SMC proliferation after vascular
injury is mediated by a pathway amenable to pharmacologic manipulation. (J Vasc Surg 2005;42:772-80.)
Clinical Relevance: After an endothelial-denuding injury such as angioplasty, SMCs are directly exposed to hemodynamic
forces such as shear stress. Although the exact nature of the shear stress towhich the SMCs are exposed in vivo has not yet been
defined, the shear-stress forces are likely to be complicated or even turbulent. The orbital shaker produces shear stress that
directly stimulates SMCproliferation, suggesting its usefulness as an in vitromodel. Because orbital shear-stress-induced SMC
proliferation and phenotype modulation is at least partly mediated by the ERK1/2 pathway, shear-stress-stimulated SMC
proliferation after vascular injury may be mediated by a pathway amenable to pharmacologic manipulation.Although endothelial cells are ordinarily thought to be
the only cells exposed to arterial shear stress, smooth mus-
cle cells (SMCs) may also be directly exposed to arterial
shear stress after an endothelial-denuding injury such as
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772balloon angioplasty. In addition, interstitial blood flow
through the overlying intact endothelial monolayer may
expose SMCs to lower magnitudes of shear stress in the
absence of a completely denuding injury; in some models,
the magnitude of this interstitial blood flow to which SMCs
are ordinarily exposed in vivo, in absence of an injury, may
approximate arterial magnitudes of shear stress.1-3
In vitro laminar flow models have demonstrated that
direct exposure of SMCs to laminar shear stress reduces
3[H]thymidine incorporation and proliferation,4,5 increases
basic fibroblast growth factor, angiotensin-converting en-
zyme, and inducible nitric oxide synthase expression,6,7
increases cyclic guanosine 3=,5=-monophosphate, tissue
plasminogen activator, and nitric oxide production,8 and
increases fibroblast growth factor-2 release.9 However, the
relevance of these in vitro responses of SMCs to laminar
shear stress is unclear, as the characteristics of the shear
stress to which SMCs are exposed after endothelial cell
injury in vivo (ie, laminar versus disturbed or turbulent
shear stress) are not clear. Orbital and oscillatory patterns of
shear stress in areas of disturbed flow lead to plaque forma-
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cells in vitro.10,11
Orbital shear stress activates endothelial cell mitogen-
activated protein kinase (MAPK) and pp70s6k pathways
and stimulates endothelial cell translation as well as DNA
synthesis.12-14 We have previously demonstrated that
short-term exposure to orbital shear stress directly stimu-
lates SMC proliferation and Akt phosphorylation.15 To
determine whether sustained orbital shear stress stimulates
SMC proliferation, we examined the activation and func-
tional significance of the MAPK extracellular signal-
regulated protein kinase 1/2 (ERK1/2) pathway as a po-
tential mechanism for orbital shear-stress-stimulated SMC
proliferation in long term culture in vitro.
MATERIALS AND METHODS
Bovine aortic SMCs were obtained as previously de-
scribed and maintained in Dulbecco modified Eagle me-
dium F-12 (GIBCO BRL, Gaithersburg, Md) supple-
mented with 10% fetal bovine serum (FBS), 5 g/mL
deoxycytidine/thymidine (Sigma Chemical, St Louis,
Mo), and antibiotics (penicillin, 100 U/L; streptomycin,
100 /mL; amphotericin B, 250 ng/mL) at 37oC in a
humidified incubator with 5% carbon dioxide.15
Cells of passage 4 to 6 were seeded at a subconfluent
density of 50,000/cm2 on six-well plates coated with col-
lagen type I. Cells that were seeded only in the center or
only on the periphery of the well were excluded from the
unseeded part of the well. To prevent cell attachment, the
unseeded area was covered with a silicone gasket that was
removed before shear stress exposure. The center area
available for seeding was 1.54 cm2, and 2.92 cm2 was
available in the periphery area.16
Cells were exposed to 210 rpm orbital shear stress for
up to 10 days using an orbital shaker (DS-500, VWR
International, West Chester, Penn), as previously de-
scribed.13,15-17 Shear-stress experiments that measured
proliferation were performed in the presence of 10% FBS
after synchronization by incubation for 24 hours in FBS-
free media, and in the additional presence or absence of the
MAPK ERK1/2 pathway inhibitor PD98059 (10 M) or
the MAPK p38 pathway inhibitor SB203580 (10 M).
The medium was changed every 2 days. Shear-stress exper-
iments that measured ERK1/2 phosphorylation were per-
formed in serum-free medium to prevent serum activation
of the ERK1/2 pathway.
SMC proliferation was assessed by the determination of
cell number with a Coulter-Counter (Model ZM, Coulter
Electronics, Hialeah, Fla), with some representative sam-
ples verified independently with a hemocytometer. Each
value was the mean of four counts. SMC morphology was
evaluated with hematoxylin and eosin staining. Proliferat-
ing cell nuclear antigen (PCNA) staining was evaluated by
counting the percentage of positively stained nuclei in five
high-power microscopic fields; only definitive nuclear
staining was counted.
Western blotting was performed with equal amounts of
protein (30 g) using anti-PCNA antibody (Santa CruzBiotechnology, Santa Cruz, Calif), anti--actin antibody,
anti--actin antibody, antivimentin antibody, anticalponin
antibody (Sigma), anti-ERK1/2 antibody, or antiphospho-
specific ERK1/2 antibody (Cell Signaling, Beverly, Mass),
before detection with enhanced chemiluminescence (Am-
ersham, Piscataway, NJ). All blots were quantified with
densitometry (BioImage, Ann Arbor, Mich).
Data were recorded as mean  SEM and compared
with analysis of variance, using the Fisher’s post hoc analy-
sis. StatView 5.0.1 software (SAS Institute, Inc, Cary, NC)
was used for the calculations. A value of P  .05 was
considered significant.
RESULTS
Sustained orbital shear stress stimulates SMC
proliferation. Bovine aortic SMCs were exposed to sus-
tained orbital shear stress (210 rpm) or static conditions in
the presence of 10% FBS and their proliferation was as-
sessed. SMCs exposed to orbital shear stress demonstrated
a 35% increase in proliferation by 5 days compared with
SMCs cultured under static conditions; by 10 days in
culture, SMCs exposed to orbital shear stress had a 75%
increase in proliferation compared with those cultured un-
der static conditions (Fig 1, A).
Because orbital shear stress generated by the orbital
shaker is not uniform across the bottom of the culture well
but is reduced in magnitude in the center of the culture
well, SMCs were differentially cultured either in the center
or in the periphery of the culture well and exposed to
orbital shear stress for 10 days (Fig 1, B).16 SMCs cultured
exclusively in the periphery of the culture well demon-
strated 103% increased proliferation compared with SMCs
grown under static conditions (P  .03); SMCs cultured
exclusively in the center of the culture well demonstrated
only 45% increased proliferation compared with static con-
ditions (P  .28).
To confirm that the orbital shear-stress-stimulated in-
crease in SMC proliferation in the periphery of the culture
well was not an artifact of being differentially cultured
exclusively in the periphery, SMCs were seeded throughout
the culture well and PCNA expression examined (Fig 1, C).
SMCs in the periphery of the culture well exposed to orbital
shear stress demonstrated a sixfold increase in PCNA ex-
pression compared with static conditions (P .003); SMCs
in the center of the culture well exposed to orbital shear
stress demonstrated only a 2.5-fold increased expression
compared with static conditions (P  .15). The morphol-
ogy of SMCs grown under static and orbital shear stress
conditions for 10 days is demonstrated in Fig 1, D; SMCs in
the periphery demonstrate alignment perpendicular to the
direction of flow.
Since orbital shear stress stimulates SMC proliferation
over 10 days in vitro, we determined whether this increased
proliferation was accompanied by a change in SMC pheno-
type markers. -Actin, a marker of the SMC contractile
phenotype, was decreased in SMCs after 10 days in culture;
however, -actin was significantly decreased (43%) to a
greater extent in SMCs exposed to orbital shear stress, with
ection
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A). Similarly, calponin was decreased 18%, with a 22%
decrease in the periphery (Fig 2, B). Vimentin, a marker of
Fig 1. Proliferation and morphology of smooth muscle
the time course of SMC numbers for 10 days. SMCs e
increased cell numbers compared with static (●) conditio
7 and 10, P .01 and P .002, respectively, post hoc).
in the whole culture well or exclusively in the center or
stress in the whole well or exclusively in the periphery of t
with static conditions (n  4; *P  .006 and P  .03, re
cells staining positively for proliferating cell nuclear antig
well demonstrated significantly increased PCNA expre
ANOVA; *periphery, P .002, post-hoc).D,Morpholo
culture well is to the right in all panels. The top pane
shear-stress conditions. The left panels are stained with h
proliferating cell nuclear antigen (PCNA). SMCs expo
slightly elongated and aligned perpendicularly to the dirthe SMC synthetic phenotype, had 84% greater expressionin SMCs exposed to orbital shear stress compared with
SMCs cultured under static conditions (Fig 2, C). Simi-
larly, -actin had 53% greater expression in SMCs exposed
(SMCs) under orbital shear stress. A, Line graph shows
ed to orbital shear stress (Œ) demonstrated significantly
 5; P  .0001, analysis of variance [ANOVA]; *days
r graph reflects the cell density of cells seeded uniformly
hery of the culture well. SMCs exposed to orbital shear
ll exhibited significantly increased cell density compared
ively, ANOVA). C, Bar graph reflects the percentage of
C exposed to orbital shear stress in the periphery of the
 compared with static conditions (n  3, P  .006,
SMCs after 10 days of culture (300). The edge of the
under static conditions; the bottom panels are under
oxylin and eosin (H&E); the right panels are stained for













sed tto orbital shear stress (Fig 2, D).
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phosphorylation. To determine a mechanism for orbital
shear-stress-stimulated SMC proliferation, the phosphory-
lation of ERK1/2, a component of the MAPK pathway
phosphorylated in response to external proliferative signals,
was examined. ERK1/2 was phosphorylated in a time-
dependent manner in response to orbital shear stress, with
maximum phosphorylation at 15 minutes (Fig 3, A). Both
basal and orbital shear-stress-stimulated ERK1/2 phos-
phorylation was inhibited by PD98059, an upstream inhib-
itor of the MAPK ERK1/2 pathway (Fig 3, B). SMCs
differentially cultured in the periphery of the well had
greater ERK1/2 phosphorylation than those differentially
cultured in the center of the well, which was inhibited by
PD98059 (Fig 3, C). These results suggest that orbital
shear stress directly stimulates phosphorylation of the
MAPK ERK1/2 pathway in SMCs.
To determine whether SMC ERK1/2 phosphorylation
Fig 2. Phenotypic modulation of smoothmuscle cells (SM
contractile phenotype, had significantly decreased expressio
of variance [ANOVA]; *P  .04, post hoc), with greater
Calponin, a marker of the SMC contractile phenotype, ha
shear stress (n 3; P .03, ANOVA; *P .03, post hoc
post hoc).C, Vimentin, a marker of the SMC synthetic phe
to orbital shear stress (n 3; P .05, ANOVA; *P .04,
well (†P .01 and *P .05, post hoc).D, -Actin, a mark
SMCs exposed to orbital shear stress (n 4; P .09, ANO
of the well (†P .02 and *P .04, post hoc). GAPDH, Gby orbital shear stress plays a role in orbital shear-stress-stimulated SMC proliferation, SMCs were cultured in vitro
for 10 days in the presence or absence of PD98059. SMCs
cultured in the whole well in the presence of orbital shear
stress had increased proliferation compared with SMCs
cultured in static conditions, which was inhibited by the
presence of PD98059 (Fig 4, A); there was no reduction of
proliferation in the presence of SB203580, an upstream
inhibitor of the MAPK p38 pathway (Fig 4, B). Similarly,
SMCs differentially cultured in the periphery of the well
demonstrated increased proliferation with orbital shear
stress, which was inhibited in the presence of PD98059
(Fig 4). These results suggest that ERK1/2 phosphoryla-
tion by orbital shear stress is a mechanism for orbital
shear-stress-stimulated SMC proliferation.
To determine whether ERK1/2 phosphorylation plays
a role in the SMC phenotype change associated with orbital
shear-stress-stimulated proliferation, phenotype modula-
tion was examined in the presence of PD98059. Compared
under orbital shear stress.A, -Actin, a marker of the SMC
Cs exposed to orbital shear stress (n3;P .04, analysis
ase in the periphery of the well (†P  .009, post hoc). B,
ificantly decreased expression in SMCs exposed to orbital
a greater decrease in the periphery of the well (†P .01,
e, had significantly increased expression in SMCs exposed
oc), with increases in both the center and periphery of the
the SMC synthetic phenotype, had increased expression in









VA),with SMCs exposed to static conditions, SMCs exposed to
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-actin, which was inhibited by PD98059 (Fig 5, A).
Fig 3. Extracellular signal-regulated protein kinase 1/2
(ERK1/2) phosphorylation with orbital shear stress. A, Time
course of ERK1/2 phosphorylation by orbital shear stress in
smooth muscle cells. Bar graph demonstrates maximal ERK1/2
phosphorylation (147%) at 15 minutes (n 4; P .0001, analysis
of variance [ANOVA]; *P  .0001, post hoc). B, Inhibition of
ERK1/2 phosphorylation with PD98059 (10 M) (n  4; P 
.002, ANOVA). The 110% increase in ERK1/2 phosphorylation is
significant (*P  .005, post hoc), as is the inhibition with
PD98059 (†P  .002, post hoc). C, Inhibition of ERK1/2 phos-
phorylation with PD98059 in smooth muscle cells differentially
cultured in the center or periphery of the culture well (n 3). The
116% increase in ERK1/2 phosphorylation in the periphery is
significant (*P  .0003, post hoc), as is the inhibition with
PD98059 (†P  .002, post hoc).SMCs cultured differentially in the periphery of the well,but not the center, also demonstrated inhibited -actin
expression with exposure to orbital shear stress, which was
inhibited by PD98059 (Fig 5, B). Similarly, compared with
SMCs exposed to static conditions, SMCs exposed to or-
bital shear stress demonstrated increased expression of vi-
mentin, which was inhibited by PD98059 (Fig 5, C). SMCs
cultured differentially in the periphery of the well, but not
the center, also demonstrated increased vimentin expres-
sion with exposure to orbital shear stress, which was inhib-
ited by PD98059 (Fig 5, D).
DISCUSSION
We demonstrate that orbital shear stress directly stim-
ulates SMC proliferation in long-term culture in vitro and
that the MAPK ERK1/2 pathway at least partly mediates
orbital shear-stress-stimulated SMC proliferation. In addi-
tion, the ERK1/2 pathway may also mediate the orbital
shear-stress-stimulated change in SMC phenotype markers.
Increased laminar blood flow through vascular grafts is
associated with decreased SMC proliferation and neointi-
mal hyperplasia in vivo18,19; corresponding in vitro models
have demonstrated decreased SMC proliferation with di-
rect exposure to laminar shear stress for 24 hours.4,5 How-
ever, since humans with carotid bifurcation stenosis live for
long periods with oscillatory and orbital flow, and since
increased SMC proliferation and ERK1/2 phosphorylation
have been reported in rat carotid arteries after balloon
injury,20,21 we believe that the orbital shear-stress model is
also a physiologically relevant model that more closely
approximates the complex, disturbed, and orbital blood
flow after an endothelial-denuding injury such as angio-
plasty than does the laminar flow model. We have previ-
ously reported that short-term exposure to orbital shear
stress increases SMC proliferation by approximately 20%,
and we extend these observations to demonstrate 75%
increased SMC proliferation over longer-term culture in
vitro (ie, 10 days).15
Although the orbital shaker does not produce uniform
laminar shear stress on the seeded cells, most of the cells are
exposed to near-maximal shear stress (max), calculated as
max a2f3
where a is the orbital radius of rotation of the shaker, 	 is
the density of the culture medium, 
 is the viscosity of the
medium, and f is the frequency of rotation.12,13 At 210
rpm, the frequency of rotation used in these experiments,
calculated max is 9.8 dyne/cm
2 and is similar to the value
that we measured (11.1 dyne/cm2) as well as the values
reported by others (11.5 dyne/cm2) and is similar to
arterial magnitudes of shear stress in vivo.13,16,22
Because the cells seeded exclusively in the periphery of
the culture well have increased proliferation, perpendicular
alignment, phenotype change, and ERK1/2 phosphoryla-
tion compared with SMCs seeded exclusively in the center
of the well, it is possible that the difference between center
and periphery effects is due to the reduced magnitude of
shear stress in the center of the well (ie, the effects of orbital
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(ERK1/2) phosphorylation. A, Bar graph demonstrates SMC density at 0 and 10 days of SMCs cultured in the whole
well or differentially cultured in the center or periphery of the well (n 4). SMCs were cultured in the presence of 10%
fetal bovine serum (FBS) and with PD98059 (10 M) or vehicle alone. For SMCs seeded in the whole culture well, the
increase in proliferation due to orbital shear stress is significant (*P  .0001, post hoc), as is the inhibition with
PD98059 (†P .0001, post hoc). For SMCs seeded only in the periphery, the increase in proliferation due to orbital
shear stress is significant (**P  .0002, post hoc), as is the inhibition with PD98059 (††P  .001, post hoc). B, Bar
graph demonstrates SMC numbers at 0 and 10 days of SMCs cultured in the whole well, in the presence of 10% FBS
and with either PD98059 (10 M), SB203580 (10 M), or vehicle alone (n  4). The increase in SMC proliferation
due to orbital shear stress is significant (*P .0008, post hoc); the reduced proliferation in the presence of the ERK1/2
pathway-inhibitor PD98059 is significant (†P  .0001, post hoc); the effect of the p38 pathway-inhibitor SB203580
was not significant (P  .20, post hoc).
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nitude of shear stress to which SMCs would be exposed in
vivo after an endothelial-denuding injury is not known;
thus, the relevance of the exact arterial magnitude of shear
stress generated in the periphery of the culture well by this
model is not clear. Reduced magnitudes of shear stress,
such as present in the center of the culture well, may also be
physiologically relevant.
Furthermore, the differences in flow between the cen-
ter and the periphery of the well in this model may be more
relevant when applied on endothelial cells than SMCs
because endothelial cells have different types of responses in
the center and periphery of the well.16 However, unlike
endothelial cells, SMCs have similar direction but different
magnitude responses in the center and periphery of the well
Fig 5. Inhibition of orbital shear-stress-induced smoot
(10 M). A, -Actin, a marker of the SMC contractile p
orbital shear stress (n  4; *P  .0005, post hoc) but wa
(†P .02, difference between orbital shear stress and PD
SMCs in the periphery (n 3; *P .009, post hoc), but w
(P .16, difference between control and PD98059, post
had 72% increased expression in SMCs exposed to orbita
1% in the additional presence of PD98059 (†P  .0001
hoc).D, Vimentin expression was increased 125% in SM
increased 29% in the additional presence of PD98059 (P
GAPDH, Glyceraldehyde-3-phosphate dehydrogenase.(Figs 1 to 5), suggesting that studies of orbital shear stresson SMCs may be relevant even if the entire culture well is
totally used, without differential culture.
We demonstrate that orbital shear stress directly stim-
ulates ERK1/2 phosphorylation and that both basal and
orbital shear-stress-stimulated SMC proliferation depends,
at least in part, on activation of the MAPK ERK1/2 path-
way. These findings are consistent with the increased acti-
vation of this pathway in response to growth factor stimu-
lation of SMC proliferation.23-30 ERK1/2 is phosphor-
ylated at very low levels in SMC in vivo, and the
overlying endothelial monolayer ordinarily prevents
ERK1/2 phosphorylation by physiologic levels of shear
stress.31 ERK1/2 is more closely linked to SMC prolifera-
tion than other MAPKs, such as the Jun N-terminal kinase
or p38 pathways, consistent with our data demonstrating
scle cell (SMC) phenotype modulation with PD98059
type, had 71% decreased expression in SMCs exposed to
y decreased 41% in the additional presence of PD98059
9, post hoc). B, -Actin expression was reduced 72% in
ly decreased 31% in the additional presence of PD98059
C,Vimentin, a marker of the SMC synthetic phenotype,
r stress (n 3; *P .0001, post hoc) but was decreased
erence between orbital shear stress and PD98059, post
the periphery (n 4; *P .002, post hoc) but was only









 .4that orbital shear-stress-induced SMC proliferation specif-
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(Fig 4, B).32,33
Several strategies, including the use of dominant negative
mutants or antisense oligonucleotides, can specifically inhibit
ERK1/2 activity and thus inhibit SMC proliferation in
vivo.34,35 We used PD98059, a small, cell-permeable mole-
cule that is a specific inhibitor of MAPK kinase-1 (MEK)36
because PD98059 does not inhibit p70 S6 kinase, phospho-
lipase C, Raf-kinase, cyclic adenosinemonophosphate-depen-
dent kinase, protein kinase C, v-Src, endothelial growth
factor receptor kinase, PDGF receptor kinase, or PI3K at
the concentrations used in this study.37-39 Although the
use of chemical inhibitors is less specific than some tech-
niques used to inhibit signal transduction, such as the use of
dominant negative mutations or the use of cells derived
from appropriate knockout mice, PD98059 has similar
specificity to antisense oligonucleotides37; nevertheless, it is
possible that PD98059 inhibits other intracellular signal
transduction pathways.
SMCs are heterogeneous; in atherosclerotic-prone ar-
teries or after injury, groups or subgroups of SMCs prolif-
erate and migrate, resulting in pathology such as plaque or
restenosis.40-43 The increase in SMC proliferation and mi-
gration is associated with a switch from the contractile to
the synthetic phenotype.44,45 Sustained phosphorylation of
ERK1/2 has been demonstrated to play an essential role in
the contractile-to-synthetic phenotype switch; culture in
vitro was also associated with a decreased number of cellular
filaments that was partially reversed by PD98059.46 Simi-
larly, -actin expression is decreased in SMCs cultured in
vitro.47 We demonstrate that -actin expression is de-
creased in the presence of shear stress beyond that because
of static in vitro culture conditions (Fig 2, A) and may be
partially reversed by PD98059 (Fig 5, A and B). Similar
results were obtained with immunohistochemistry (data
not shown).
This suggests that targeting the ERK1/2 pathway to
inhibit restenosis not only may inhibit SMC proliferation,
but also may preserve the SMC contractile phenotype that
is thought to be present in the quiescent arterial wall.
However, because the effects of orbital shear stress on
SMCs derived from smaller vessels may be different than
the effects on SMCs derived from larger vessels, as used in
this study, examination of the effects of orbital shear stress
on SMCs derived from humans and smaller-diameter ves-
sels may be useful.
We demonstrate decreased -actin and calponin ex-
pression and increased vimentin and -actin expression
with shear stress. Additional markers, such as SM22,
myosin heavy chain, desmin, and smoothelin, may be af-
fected but are not consistently detectable in bovine cells
(data not shown).41 However, taken in toto, our results
suggest that shear stress directly affects not only SMC
proliferation but also SMC phenotype by the ERK1/2
pathway.
The genes that control the regulation of SMC pheno-
type are beginning to be understood.48 If higher level
regulatory genes, such as myocardin,49,50 are responsive toshear stress, then differences in response due to laminar and
orbital shear stress may be a potential mechanism for the
control of SMC phenotype in vivo. In addition, since SMCs
respond directly to shear stress, the shear-stress receptor
may be a common feature of both endothelial cells and
SMCs.51,52
CONCLUSION
Orbital shear stress directly stimulates SMC prolifera-
tion and expression of markers of the synthetic phenotype
via the ERK1/2 pathway. These results suggest a mecha-
nism for SMC proliferation after an endothelial-denuding
injury in vivo and that this response activates a pathway
amenable to pharmacologic manipulation.
We acknowledge the thoughtful comments and sug-
gestions made by Bill Sessa.
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